S Tsuruta

Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2

Naota Taura, Tatsuki Ichikawa, Hisamitsu Miyaaki et al. · Gastroenterology Research and Practice · 2012 · 129 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma

Hiroki Ishikawa, Kensuke Nakata, Fumihiro Mawatari et al. · Gene Therapy · 1999 · 41 citations

Medicine, Molecular Biology, Oncology +14

Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.

Fumihiro Mawatari, S Tsuruta, Akira Ido et al. · PubMed · 1999 · 32 citations

Medicine, Molecular Biology, Oncology +13

Beta-lipoproteins influence the serum level of hepatitis C virus.

Munechika Enjoji, Makoto Nakamuta, Noriko Kinukawa et al. · PubMed · 2001 · 32 citations

Life Sciences, Biochemistry, Infectious Diseases +15

Detection of hepatitis B virus X-region DNA in liver tissue from patients with hepatitis C virus-associated cirrhosis who subsequently developed hepatocellular carcinoma.

Yoshisada Shibata, Keisuke Nakata, S Tsuruta et al. · International Journal of Oncology · 1999 · 23 citations

Medicine, Infectious Diseases, Molecular Biology +17